Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …

Many pathogens invade the host at the intestinal surface. To protect against these
enteropathogens, the induction of intestinal secretory IgA (SIgA) responses is paramount …

Malaria, caused by the protozoan Plasmodium, is a devastating disease with over 200
million new cases reported globally every year. Although immunization is arguably the best …

Highlights•Carbohydrate-based adjuvants are safe, biocompatible and capable to stimulate
strong and long-lasting humoral and cellular immune responses.•Lipid A derived …

Malaria as vector-borne disease remains important health concern with over 200 million
cases globally. Novel antimalarial medicines and more effective vaccines must be …

Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily
restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance …

Introduction Vaccine development for the disease caused by the herpes simplex virus (HSV)
has been challenging over the years and is always in dire need of novel approaches for …

Infectious diseases represent a major cause of deaths worldwide. No vaccine or effective
treatment exists nowadays, especially against intracellular pathogens. The increase in …

Backgrounds Malaria, a preventive and treatable disease, is still responsible for annual
deaths reported in most tropical regions, principally in sub-Saharan Africa. Subunit …

It is obvious that there is a critical need for an efficient malaria vaccine to accelerate malaria
eradication. Currently, recombinant subunit vaccination against malaria using proteins and …